Anthem Biosciences Ltd Quarterly Results

Gross Sales

550.03

540.21

483.2

497.81

524.96

Excise Duty

0

0

0

0

0

Net Sales

550.03

540.21

483.2

497.81

524.96

Other Operating Income

0

0

0

0

0

Other Income

48.23

22.81

14.06

24.37

27.85

Total Income

598.26

563.02

497.26

522.18

552.8

Total Expenditure

332.12

348.72

288

338.3

329.73

PBIDT

266.13

214.3

209.26

183.88

223.07

Interest

3.03

1.61

0.52

2.55

3.55

PBDT

263.1

212.69

208.73

181.33

219.52

Depreciation

33.5

26.45

30.42

20.28

19.99

Minority Interest Before NP

0

0

0

0

0

Tax

63.75

50.07

61.58

37.72

52.09

Deferred Tax

-7.58

0.39

34.11

-1.01

-14.49

Reported Profit After Tax

173.43

135.79

82.62

124.33

161.93

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

173.43

135.79

82.62

124.33

161.93

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

173.43

135.79

82.62

124.33

161.93

EPS (Unit Curr.)

3.09

2.43

1.48

2.22

2.9

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

112.32

112.32

111.82

111.82

112.32

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

48.38

39.66

43.3

36.93

42.49

PBDTM(%)

47.83

39.37

43.19

36.42

41.81

PATM(%)

31.53

25.13

17.09

24.97

30.84